LSX World Congress 

Partnering, strategy & investment for life science executive leaders

10-11 May 2022 | In person event | Location: 133 Houndsditch, London 

Join Anne Horgan who will take part in the following panel discussion "Moving The Needle - successful business models at the interface between industry, academia and investment" 

The pace of innovation in biotech and life sciences is only increasing and keeping at the cutting edge of new discoveries and next generation technologies is key. Pharma and investors are looking ever earlier to help support these ideas, alongside TTOs and accelerators, to translate early innovation into viable start-ups which can in turn then get treatments and technologies from the lab to the bedside as quickly as possible. A multi-stakeholder panel discusses evolving businesses models, stories of success, and how the whole ecosystem can work more effectively together.

  • How to get new technology into commercially viable entities more quickly
  • Learning from the successes in the UK ecosystem and how these models can be implemented in other clusters
  • What more needs to be done to expedite translation of innovation?


  • Bill Haynes, Head of Novo Nordisk Research Centre Oxford, Novo Nordisk
  • Anne Horgan, Partner, Cambridge Innovation Capital
  • Dima Kuzmin, Managing Director, 4BIO Capital
  • Jason Mellad, CEO, Start Codon

Connecting life science executives & investors

The 8th LSX World Congress gathers the founders and CEOs of innovative start-ups through to healthcare giants, and everyone in between. It represents the breadth and depth of the cutting-edge research and technology driving the advances in the industry right now and in the near future.

Find out more about the event and register here to attend